Thursday, October 27, 2011

A decade after after duping bioethicists, Lilly pulls the plug on Xigris

Remember Xigris?  The enormously expensive sepsis drug that Lilly hyped by buying off bioethicists?  Ten years after its launch, a new study has shown that Xigris does not help patients live longer, so Lilly is pulling the drug from the market.  Read about it here.

No comments:

Post a Comment